Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review
暂无分享,去创建一个
C. Buonerba | G. Lazzari | R. Solla | Salvatore Pisconti | G. Della | Vittoria Scarpati | S. Messinese | R. Carella | Massimiliano Marzo | Francesco Perri | Giuseppe Lorenzo
[1] P. Houghton,et al. Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force , 2019, F1000Research.
[2] G. Nicholas,et al. Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors , 2017, Case Reports in Oncology.
[3] Yong-Koo Park,et al. Ewing sarcoma: a chronicle of molecular pathogenesis. , 2016, Human pathology.
[4] A. Llombart‐Bosch,et al. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. , 2016, Annals of diagnostic pathology.
[5] S. Lessnick,et al. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting , 2016, Oncotarget.
[6] C. Fletcher,et al. Round cell sarcomas - biologically important refinements in subclassification. , 2014, The international journal of biochemistry & cell biology.
[7] M. Sharma,et al. Outcomes and prognostic factors for Ewing-family tumors of the extremities. , 2014, The Journal of bone and joint surgery. American volume.
[8] C. Antonescu. Round cell sarcomas beyond Ewing: emerging entities , 2014, Histopathology.
[9] Abha A. Gupta,et al. Optimal Management of Ewing Sarcoma Family of Tumors: Recent Developments in Systemic Therapy , 2013, Pediatric Drugs.
[10] D. Osuna,et al. Advances in Ewing's sarcoma research: where are we now and what lies ahead? , 2009, Cancer research.
[11] A. Lazar,et al. Ewing’s Sarcoma: Standard and Experimental Treatment Options , 2009, Current treatment options in oncology.
[12] K. Laschinger,et al. Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship. , 2008, Clinical journal of oncology nursing.
[13] E. Ademoglu,et al. Ewing sarcoma in a geriatric patient , 2005, Aging clinical and experimental research.
[14] J. Khoury. Ewing Sarcoma Family of Tumors , 2005, Advances in anatomic pathology.
[15] Hiroshi Kobayashi,et al. [Soft tissue sarcoma: postoperative chemotherapy]. , 2004, Gan to kagaku ryoho. Cancer & chemotherapy.
[16] C. Roberts,et al. The insulin-like growth factor system and cancer. , 2003, Cancer letters.
[17] X. Shu,et al. Insulin-like growth factors and breast cancer risk in Chinese women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[18] Christopher T Denny,et al. Biology of EWS/ETS fusions in Ewing's family tumors , 2001, Oncogene.
[19] M. Raffeld,et al. Molecular Confirmation of Ewing Sarcoma , 2001, Journal of pediatric hematology/oncology.
[20] J. Pelletier,et al. Molecular genetics of chromosome translocations involving EWS and related family members. , 1999, Physiological genomics.
[21] F. Gudat,et al. Molecular Diagnosis of Ewing Tumors: Improved Detection of EWS‐FLI‐1 and EWS‐ERG Chimeric Transcripts and Rapid Determination of Exon Combinations , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[22] G. Thomas,et al. Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors. , 1997, Cancer genetics and cytogenetics.
[23] P. Lollini,et al. Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target. , 1996, Cancer research.
[24] C. Denny,et al. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 , 1993, Molecular and cellular biology.
[25] D. Yee,et al. Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. , 1990, The Journal of clinical investigation.
[26] R. Heyn. The role of chemotherapy in the management of soft tissue sarcomas , 1975, Cancer.
[27] H. Gelderblom,et al. Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway. , 2016, European journal of cancer.
[28] D. Ranchère‐Vince,et al. [Ewing/PNET sarcoma family of tumors: towards a new paradigm?]. , 2015, Annales de pathologie.
[29] Wen-Qi Jiang,et al. [Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy]. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.
[30] B. Seddon,et al. Emerging Chemotherapeutic Strategies and the Role of Treatment Stratification in Ewing Sarcoma , 2008, Paediatric drugs.
[31] C. Denny,et al. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor. , 1997, Current topics in microbiology and immunology.